APPLICATION
NDA016149
TYPE
NDA
ORIGINAL APPROVAL
1967-06-19
LATEST ACTION
1981-01-29
ROUTE
ORAL
DOSAGE FORM
CONCENTRATE
MARKETING STATUS
Discontinued
Products
TARACTANDiscontinued
CHLORPROTHIXENE 100MG/5ML · CONCENTRATE · ORAL
Approval history
1981-01-29Labeling · Supplement 24 · standardAP
1979-05-04Manufacturing (CMC) · Supplement 20 · standardAP
1979-01-10Manufacturing (CMC) · Supplement 22 · standardAP
1979-01-10Labeling · Supplement 21 · standardAP
1976-09-10Manufacturing (CMC) · Supplement 19 · standardAP
1974-06-16Labeling · Supplement 13 · standardAP
1967-06-19Type 3 - New Dosage Form · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.